GlassScriptPhysician profile
Wesley M Foster
NPI 1942294418
$1,619.24
in general payments reported to CMS, 2019-2025
23 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $124 · 2021: $202 · 2022: $176 · 2023: $355 · 2024: $178 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $362.35 | 2019-2025 | Novasure, Thinprep 2000 Processor, Aptima |
| Mayne Pharma Commercial LLC | $266.56 | 2023-2025 | |
| Abbvie INC. | $106.79 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.21 | 2019-2025 | |
| Astellas Pharma US INC | $67.45 | 2023-2025 | Veozah |
| Meditrina | $66.13 | 2019-2021 | |
| Organon LLC | $65.29 | 2021-2024 | Nexplanon |
| Shield Therapeutics INC | $61.32 | 2023-2025 | Accrufer |
| Coopersurgical, INC. | $61.02 | 2020-2022 | |
| Exact Sciences Corporation | $58.51 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $48.88 | 2019 | |
| Pfizer INC. | $47.18 | 2019-2024 | |
| Vertex Pharmaceuticals Incorporated | $46.01 | 2024-2025 | |
| Biogen, INC. | $45.62 | 2023-2025 | Spinraza, Zurzuvae |
| Radius Health, INC. | $43.88 | 2023 | Tymlos |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $36.82 | 2020-2023 | Intrarosa, Femring |
| Daiichi Sankyo INC. | $31.88 | 2019 | |
| Dysis Medical, INC. | $27.59 | 2022 | |
| Covidien LP | $21.41 | 2019 | |
| Minerva Surgical, INC | $18.60 | 2024 | |
| Allergan, INC. | $17.10 | 2019 | |
| Medtronic, INC. | $15.82 | 2021 | |
| Exeltis, USA INC. | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.